Ben S. Michelson

Array ( [id] => 9643315 [patent_doc_number] => 20140221427 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-07 [patent_title] => 'ISOTOPOLOGUES OF POMALIDOMIDE' [patent_app_type] => utility [patent_app_number] => 14/128412 [patent_app_country] => US [patent_app_date] => 2012-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19979 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14128412 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11408852 [patent_doc_number] => 09556144 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-31 [patent_title] => 'Compound as WNT signaling inhibitor, composition, and use thereof' [patent_app_type] => utility [patent_app_number] => 14/408254 [patent_app_country] => US [patent_app_date] => 2012-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15023 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14408254 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9286433 [patent_doc_number] => 08642763 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-04 [patent_title] => 'Ni complex and its derivatives, producing method, and the use thereof as an antioxidant' [patent_app_type] => utility [patent_app_number] => 13/492657 [patent_app_country] => US [patent_app_date] => 2012-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5545 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13492657 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10574071 [patent_doc_number] => 09296699 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-29 [patent_title] => 'Reductive amination of 6-keto morphinans by catalytic hydrogen transfer' [patent_app_type] => utility [patent_app_number] => 13/491676 [patent_app_country] => US [patent_app_date] => 2012-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9192 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13491676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11799551 [patent_doc_number] => 09540341 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-10 [patent_title] => 'Crystalline forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione' [patent_app_type] => utility [patent_app_number] => 14/233444 [patent_app_country] => US [patent_app_date] => 2012-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 56 [patent_figures_cnt] => 56 [patent_no_of_words] => 13624 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14233444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10554768 [patent_doc_number] => 09278966 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-08 [patent_title] => 'Method for manufacturing oxetane compound, method for manufacturing azolylmethylcyclopentanol compound, and intermediate compound' [patent_app_type] => utility [patent_app_number] => 14/124114 [patent_app_country] => US [patent_app_date] => 2012-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27363 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14124114 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10109964 [patent_doc_number] => 09145366 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-29 [patent_title] => 'Process for preparing [(3-hydroxypyridine-2-carbonyl)amino]alkanoic acids, esters and amides' [patent_app_type] => utility [patent_app_number] => 13/488554 [patent_app_country] => US [patent_app_date] => 2012-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16698 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13488554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8586896 [patent_doc_number] => 20130005716 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-03 [patent_title] => 'DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/488818 [patent_app_country] => US [patent_app_date] => 2012-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 67411 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13488818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10601173 [patent_doc_number] => 09321727 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-26 [patent_title] => 'Pyridine derivatives as agonists of the CB2 receptor' [patent_app_type] => utility [patent_app_number] => 13/486057 [patent_app_country] => US [patent_app_date] => 2012-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 84581 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 1441 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13486057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10601173 [patent_doc_number] => 09321727 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-26 [patent_title] => 'Pyridine derivatives as agonists of the CB2 receptor' [patent_app_type] => utility [patent_app_number] => 13/486057 [patent_app_country] => US [patent_app_date] => 2012-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 84581 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 1441 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13486057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10601173 [patent_doc_number] => 09321727 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-26 [patent_title] => 'Pyridine derivatives as agonists of the CB2 receptor' [patent_app_type] => utility [patent_app_number] => 13/486057 [patent_app_country] => US [patent_app_date] => 2012-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 84581 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 1441 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13486057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10601173 [patent_doc_number] => 09321727 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-26 [patent_title] => 'Pyridine derivatives as agonists of the CB2 receptor' [patent_app_type] => utility [patent_app_number] => 13/486057 [patent_app_country] => US [patent_app_date] => 2012-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 84581 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 1441 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13486057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8503131 [patent_doc_number] => 20120302540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-29 [patent_title] => '3-SPIROCYCLIC PIPERIDINE DERIVATIVES AS GHRELIN RECEPTOR AGONISTS' [patent_app_type] => utility [patent_app_number] => 13/479596 [patent_app_country] => US [patent_app_date] => 2012-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 57372 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13479596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9657564 [patent_doc_number] => 20140228569 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-14 [patent_title] => 'NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID' [patent_app_type] => utility [patent_app_number] => 14/118317 [patent_app_country] => US [patent_app_date] => 2012-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7368 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14118317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9422500 [patent_doc_number] => 20140107151 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-17 [patent_title] => 'TYROSINE KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 14/117870 [patent_app_country] => US [patent_app_date] => 2012-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40653 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14117870 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9408996 [patent_doc_number] => 20140100248 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-10 [patent_title] => 'Novel Heterocyclic Compounds as Modulators of Sphingolipid Signaling and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 14/008114 [patent_app_country] => US [patent_app_date] => 2012-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10567 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14008114 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9192264 [patent_doc_number] => 20130331579 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-12 [patent_title] => 'Synthesis of 2-carboxamide cycloamino urea derivatives' [patent_app_type] => utility [patent_app_number] => 13/985069 [patent_app_country] => US [patent_app_date] => 2012-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7900 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13985069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9512111 [patent_doc_number] => 20140148604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-29 [patent_title] => 'PROCESS FOR PREPARING SODIUM SALTS OR POTASSIUM SALTS OF 4-HYDROXY-2-OXO-2,5-DIHYDROFURAN-3-CARBOXYLATE' [patent_app_type] => utility [patent_app_number] => 14/002695 [patent_app_country] => US [patent_app_date] => 2012-02-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3024 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14002695 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9319341 [patent_doc_number] => 20140051680 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-20 [patent_title] => 'Histone Deacetylase Inhibitors' [patent_app_type] => utility [patent_app_number] => 13/823708 [patent_app_country] => US [patent_app_date] => 2012-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 37622 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13823708 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8251967 [patent_doc_number] => 20120156290 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-21 [patent_title] => 'PROCESS FOR PREPARING OXYMORPHONE, NALTREXONE, AND BUPRENORPHINE' [patent_app_type] => utility [patent_app_number] => 13/407298 [patent_app_country] => US [patent_app_date] => 2012-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4965 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20120156290.pdf [firstpage_image] =>[orig_patent_app_number] => 13407298 [rel_patent_id] =>[rel_patent_doc_number] =>)